Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Management of Catatonic Features in Adolescents With Profound Autism
NCT07498387Active, not recruiting
- Sponsor
- Tanta University
- Start
- Jan 2026
- Primary completion
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of clonazepam and midazolam in catatonia, sponsored by Tanta University. Primary endpoint: Pediatric Catatonia Rating Scale at 12 weeks. Started Jan 2026; status: active, not recruiting.
02
Drugs
clonazepammidazolam
03
Conditions
catatonia
Beyond the preview
Go deeper on NCT07498387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07498387.